Robert Plenge
Fortune : 2 M $ au 31/07/2026
Fortune : 2 M $ au 31/07/2026
Robert M.
Plenge is currently Director at PhRMA Foundation and Chief Research Officer, EVP & Head-Research at Bristol Myers Squibb Co. Former positions include Independent Director at Translate Bio, Inc. from 2019 to 2021, VP-Translational Development & Research at Celgene Corp., Vice President & Head-Translational Medicine at Merck & Co., Inc. from 2013 to 2017, Associate Member-Broad Institute at The Brigham & Women's Hospital, Inc. from 2007 to 2013, and Associate Member at The Broad Institute, Inc. from 2007 to 2013.
Education includes a doctorate from Case Western Reserve University conferred in 2000 and an undergraduate degree from the University of California San Diego conferred in 1992.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 10/03/2026 | 24 754 ( 0 % ) | 2 M $ | 31/07/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Directeur Technique/Scientifique/R&D | 01/11/2019 |
PhRMA Foundation
PhRMA Foundation Miscellaneous Commercial ServicesCommercial Services Engages in research and development of drugs | Directeur/Membre du Conseil | - |
| Sociétés | Poste | Fin |
|---|---|---|
| TRANSLATE BIO, INC. | Directeur/Membre du Conseil | 14/09/2021 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01/05/2017 |
The Brigham & Women's Hospital, Inc.
The Brigham & Women's Hospital, Inc. Hospital/Nursing ManagementHealth Services Provides health care services | Corporate Officer/Principal | 01/01/2013 |
The Broad Institute, Inc.
The Broad Institute, Inc. BiotechnologyHealth Technology Engages in research and development in bio medicals to cure infectious disease, cancer, psychiatric research and cardiovascular diseases | Corporate Officer/Principal | 01/01/2013 |
| CELGENE | Directeur Technique/Scientifique/R&D | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 9 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Merck & Co., Inc.
Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Translate Bio, Inc.
Translate Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage mRNA therapeutics company that develops transformative medicines to treat diseases caused by protein | Health Technology |
The Brigham & Women's Hospital, Inc.
The Brigham & Women's Hospital, Inc. Hospital/Nursing ManagementHealth Services Provides health care services | Health Services |
Case Western Reserve University
Case Western Reserve University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California San Diego
University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Broad Institute, Inc.
The Broad Institute, Inc. BiotechnologyHealth Technology Engages in research and development in bio medicals to cure infectious disease, cancer, psychiatric research and cardiovascular diseases | Health Technology |
PhRMA Foundation
PhRMA Foundation Miscellaneous Commercial ServicesCommercial Services Engages in research and development of drugs | Commercial Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national